Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Divis to spend Rs 300 crore on expansion plans in 2018

      Divis to spend Rs 300 crore on expansion plans in 2018

      Ruby Khatun Khatun31 Jan 2018 10:45 AM IST
      HYDERABAD: Drug firm Divis Laboratories is focussed on expanding capacities of existing plants, even as its proposed plant at Kakinada, Andhra Pradesh...
      Novartis India Q3 net profit up 44 percent at Rs 18.74 crore

      Novartis India Q3 net profit up 44 percent at Rs 18.74 crore

      Ruby Khatun Khatun31 Jan 2018 10:30 AM IST
      New Delhi: Novartis India reported a 43.82% increase in net profit at Rs18.74 crore for the third quarter ended December 2017.The company had posted a...
      Biocon, Mylan receive Positive CHMP opinion for Insulin Glargine

      Biocon, Mylan receive Positive CHMP opinion for Insulin Glargine

      Ruby Khatun Khatun31 Jan 2018 10:18 AM IST
      Bengaluru: Mylan N.V. and Biocon Ltd. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued...
      Top Indian lawyers to argue Ranbaxy-Daiichi appeal in Singapore

      Top Indian lawyers to argue Ranbaxy-Daiichi appeal in Singapore

      Ruby Khatun Khatun31 Jan 2018 10:15 AM IST
      India's two top lawyers will be arguing in the Singapore Court of Appeal the case of Japan's Daiichi Sankyo Company and Ranbaxy Laboratories of India,...
      Policy Direction will be the major focus of Union Budget 2018 for Healthcare

      Policy Direction will be the major focus of Union Budget 2018 for Healthcare

      Ruby Khatun Khatun31 Jan 2018 10:00 AM IST
      By Ameera Shah- Promoter and Managing Director, Metropolis Healthcare LtdAs the nation looks forward to the Union Budget of 2018, there is a lot of...
      Takeda gets USFDA fast track status for Zika vaccine

      Takeda gets USFDA fast track status for Zika vaccine

      Ruby Khatun Khatun31 Jan 2018 10:00 AM IST
      Japan’s Takeda Pharmaceutical Co Ltd said the U.S. Food and Drug Administration had granted ‘fast track’ status to its vaccine for the mosquito-borne...
      Blockchain-based healthcare setup Healthureum launched

      Blockchain-based healthcare setup Healthureum launched

      Ruby Khatun Khatun31 Jan 2018 9:45 AM IST
      New Delhi: Health-based startup from Estonia has announced 'Healthureum' a blockchain based healthcare system which is devised to combat the current...
      Google venture arm backs UK universal flu vaccine company

      Google venture arm backs UK universal flu vaccine company

      Ruby Khatun Khatun31 Jan 2018 9:30 AM IST
      LONDON: A private British company developing a vaccine that could be the first in the world to fight all types of flu has raised 20 million pounds...
      NPPA to meet top Cardiologists, Stent Makers, medical bodies on stent price revision

      NPPA to meet top Cardiologists, Stent Makers, medical bodies on stent price revision

      Ruby Khatun Khatun30 Jan 2018 3:42 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      Sanofi buys Ablynx for 4.8 billion dollars in biotech mergers and acquisitions boom

      Sanofi buys Ablynx for 4.8 billion dollars in biotech mergers and acquisitions boom

      Ruby Khatun Khatun30 Jan 2018 10:31 AM IST
      PARIS/LONDON: French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and...
      eKincare raises Rs 9.55 crores in series A funding

      eKincare raises Rs 9.55 crores in series A funding

      Ruby Khatun Khatun30 Jan 2018 10:31 AM IST
      New Delhi: Hyderabad-based eKincare said it has secured USD 1.5 million (Rs 9.55 crore) in a Series A round of funding from Ventureast, Endiya...
      Novartis India appoints Jawed Zia as new vice chairman and MD from March 2018

      Novartis India appoints Jawed Zia as new vice chairman and MD from March 2018

      Ruby Khatun Khatun30 Jan 2018 10:30 AM IST
      New Delhi: The board of directors of Novartis India announced the appointment of Jawed Zia as vice chairman and managing director of the company...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok